Reid G. Adler - 30 Jun 2023 Form 4 Insider Report for Vistagen Therapeutics, Inc. (VTGN)

Role
CHIEF LEGAL OFFICER
Signature
/s/ Jerrold D. Dotson, Attorney-in-Fact
Issuer symbol
VTGN
Transactions as of
30 Jun 2023
Net transactions value
+$265
Form type
4
Filing time
05 Jul 2023, 16:05:12 UTC
Previous filing
19 Aug 2022
Next filing
03 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTGN Common Stock Award $265 +167 +1.5% $1.59* 11,488 30 Jun 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan ("ESPP").